Effectiveness of Using a Metformin-Glimepiride Combination for Reducing Fasting Blood Sugar Levels in Patients with Type 2 Diabetes Mellitus at Dr. Abdul Azis Regional General Hospital (RSUD)
Pharmaceutical Journal · 2026
DOI: 10.67865/1bjn5x13 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmaceutical Journal, 2026. Verfasst von Syafika. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Themen: Diabetes mellitus
Abstract (Originalsprache)
Diabetes mellitus (DM) is a chronic metabolic disease characterized by elevated blood glucose levels due to impaired insulin action and secretion. Type 2 diabetes mellitus (T2DM) requires attention because its prevalence continues to increase both globally and in Indonesia. The progressive nature of T2DM may make glycemic control increasingly difficult, causing monotherapy to become insufficient to achieve glycemic targets and necessitating combination therapy with complementary mechanisms of action. The combination of metformin and glimepiride is used because metformin improves insulin sensitivity and reduces hepatic glucose production, while glimepiride stimulates insulin secretion from pancreatic beta cells. This study aimed to analyze the effectiveness of metformin-glimepiride combination therapy in reducing fasting blood glucose (FBG) levels in patients with T2DM at RSUD dr. Abdul Aziz. This study employed an observational analytic design with a cross-sectional approach and retrospective data collection using patient medical records. A total of 92 patients receiving metformin-glimepiride combination therapy were selected using purposive sampling. The collected data included patient characteristics, comorbidities, and FBG levels before and after receiving combination therapy. Data were analyzed using the Wilcoxon test. The results showed a statistically significant difference in FBG levels before and after metformin-glimepiride combination therapy (p = 0.000). The study concluded that metformin-glimepiride combination therapy was effective in reducing FBG levels in patients with T2DM. Keywords: Type 2 diabetes mellitus, effectiveness, fasting blood glucose, metformin-glimepiride combination, comorbidities. Diabetes mellitus (DM) is a chronic metabolic disease characterized by elevated blood glucose levels due to impaired insulin action and secretion. Type 2 diabetes mellitus (T2DM) requires attention because its prevalence continues to increase both globally and in Indonesia. The progressive nature of T2DM may make glycemic control increasingly difficult, causing monotherapy to become insufficient to achieve glycemic targets and necessitating combination therapy with complementary mechanisms of action. The combination of metformin and glimepiride is used because metformin improves insulin sensitivity and reduces hepatic glucose production, while glimepiride stimulates insulin secretion from pancreatic beta cells. This study aimed to analyze the effectiveness of metformin-glimepiride combination therapy in reducing fasting blood glucose (FBG) levels in patients with T2DM at RSUD dr. Abdul Aziz. This study employed an observational analytic design with a cross-sectional approach and retrospective data collection using patient medical records. A total of 92 patients receiving metformin-glimepiride combination therapy were selected using purposive sampling. The collected data included patient characteristics, comorbidities, and FBG levels before and after receiving combination therapy. Data were analyzed using the Wilcoxon test. The results showed a statistically significant difference in FBG levels before and after metformin-glimepiride combination therapy (p = 0.000). The study concluded that metformin-glimepiride combination therapy was effective in reducing FBG levels in patients with T2DM. Keywords: Type 2 diabetes mellitus, effectiveness, fasting blood glucose, metformin-glimepiride combination, comorbidities.
Zitieren
APA
Syafika (2026). Effectiveness of Using a Metformin-Glimepiride Combination for Reducing Fasting Blood Sugar Levels in Patients with Type 2 Diabetes Mellitus at Dr. Abdul Azis Regional General Hospital (RSUD). Pharmaceutical Journal. https://doi.org/10.67865/1bjn5x13
Vancouver
Syafika. Effectiveness of Using a Metformin-Glimepiride Combination for Reducing Fasting Blood Sugar Levels in Patients with Type 2 Diabetes Mellitus at Dr. Abdul Azis Regional General Hospital (RSUD). Pharmaceutical Journal. 2026. doi:10.67865/1bjn5x13
BibTeX
@article{Syafika2026,
author = {Syafika},
title = {Effectiveness of Using a Metformin-Glimepiride Combination for Reducing Fasting Blood Sugar Levels in Patients with Type 2 Diabetes Mellitus at Dr. Abdul Azis Regional General Hospital (RSUD)},
journal = {Pharmaceutical Journal},
year = {2026},
doi = {10.67865/1bjn5x13}
}
EUVIMED